Conquering Diseases

A Research Treatment for Hematopoietic Stem Cell Transplant Patients with CMV


Seeking male & females 16 years or older who are Hematopoietic Stem Cell Transplant (HSCT) recipients with asymptomatic Cytomegalovirus (CMV) infections


The main goal of this study is to see if the study drug works to clear CMV infections from the blood in stem cell transplant recipients with a CMV infection.

What we're hoping for

We are hoping that the study might give information that will help other people with CMV.

Additional Information Identifier: NCT02927067

 Principal Investigator

Laura L Gibson, MD

University of Massachusetts Medical School

 Study Contact

Jennifer  Germain



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655